Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
GlaxoSmithKline
|
| gptkbp:acquisitionYear |
2012
|
| gptkbp:focus |
drug development
human gene discovery |
| gptkbp:foundedIn |
1992
|
| gptkbp:founder |
gptkb:William_A._Haseltine
|
| gptkbp:headquartersLocation |
gptkb:Rockville,_Maryland,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableCollaboration |
gptkb:Cambridge_Antibody_Technology
GlaxoSmithKline |
| gptkbp:notableContributor |
genomics
protein therapeutics monoclonal antibodies |
| gptkbp:notableInvention |
human gene sequences
|
| gptkbp:notableProduct |
gptkb:Benlysta
|
| gptkbp:numberOfEmployees |
approximately 1,000 (at peak)
|
| gptkbp:stockSymbol |
gptkb:HGSI
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
www.hgsi.com
|
| gptkbp:bfsParent |
gptkb:Raxibacumab
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Human Genome Sciences
|